(Q34785875)

4 August 2017

1 reference

title

Current and developing chemotherapy for CLL. (English)

1 reference

4 August 2017

1 reference

Emili Montserrat

1

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

19 Suppl

1 reference

4 August 2017

page(s)

S11-9

1 reference

Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia

4 August 2017

cites work

1 reference

12 December 2020

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

1 reference

12 December 2020

Idarubicin in low-grade non-Hodgkin's lymphomas.

1 reference

12 December 2020

Chronic lymphocytic leukemia: a changing natural history?

1 reference

12 December 2020

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

1 reference

12 December 2020

Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance

1 reference

12 December 2020

Clinical challenges in chronic lymphocytic leukemia.

1 reference

12 December 2020

Is the CHOP regimen a good treatment for advanced CLL? Results from two randomized clinical trials. French Cooperative Group on Chronic Lymphocytic Leukemia

1 reference

12 December 2020

Chronic lymphocytic leukemia

1 reference

12 December 2020

Therapy for previously untreated chronic lymphocytic leukemia: a reevaluation

1 reference

12 December 2020

Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: a phase II study

1 reference

12 December 2020

Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia

1 reference

12 December 2020

Combined therapy with Fludarabine and cyclophosphamide in relapsed/resistant patients with B-cell chronic lymphocytic leukaemia and non-Hodgkin's lymphomas

1 reference

12 December 2020

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

12 December 2020

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

1 reference

12 December 2020

Fludarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: the Spanish Group experience

1 reference

12 December 2020

Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro

1 reference

12 December 2020

Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma.

1 reference

12 December 2020

Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy

1 reference

12 December 2020

Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients

1 reference

12 December 2020

Infectious and immunosuppressive complications of purine analog therapy.

1 reference

12 December 2020

Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features.

1 reference

12 December 2020

A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia

1 reference

12 December 2020

In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Fludarabine as a modulator of cisplatin activity in human tumour primary cultures and established cell lines

1 reference

12 December 2020

Treatment of indolent lymphoma with fludarabine/mitoxantrone combination: a phase II trial

1 reference

12 December 2020

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

1 reference

12 December 2020

Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia

1 reference

12 December 2020

Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: a German multicenter phase II study

1 reference

12 December 2020

Clinical staging of chronic lymphocytic leukemia

1 reference

12 December 2020

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

1 reference

12 December 2020

Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia

1 reference

12 December 2020

The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer.

1 reference

12 December 2020

Concomitant administration of chlorambucil limits dose intensity of fludarabine in previously treated patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.

1 reference

12 December 2020

Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial.

1 reference

12 December 2020

Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative

1 reference

12 December 2020

A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study.

1 reference

12 December 2020

Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases

1 reference

12 December 2020

Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report

1 reference

12 December 2020

Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.

1 reference

12 December 2020

When and how to treat chronic lymphocytic leukemia

1 reference

12 December 2020

The experience of the French Cooperative Group in the treatment of CLL

1 reference

12 December 2020

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL

1 reference

12 December 2020

Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy

1 reference

12 December 2020

Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies

1 reference

12 December 2020

Identifiers

DOI

10.1385/MO:19:2S:S11

1 reference

Dimensions Publication ID

4 August 2017

1042949912

0 references

1 reference